Literature DB >> 2605437

Cognitive aspects of panic attacks. Content, course and relationship to laboratory stressors.

D Zucker1, C B Taylor, M Brouillard, A Ehlers, J Margraf, M Telch, W T Roth, W S Agras.   

Abstract

Twenty patients with panic attacks and ten controls were given a standardised interview about thoughts occurring during times of anxiety or panic attacks. The interviewer was blind to the subject's diagnosis. The 20 panic patients underwent a psychophysiological test battery which included a cold pressor test, mental arithmetic task, and 5.5% CO2 inhalation. More patients than controls reported thoughts centered on fears of losing control and shame when anxious. Panic patients rated their thoughts as stronger and clearer than did controls and they had more difficulty excluding them from their minds. A feeling of anxiety preceded anxious thoughts in patients. This suggests that 'faulty cognitions' are not the initial event in a panic attack, although anxious thoughts may exacerbate or maintain them. Significant correlations were found between the intensity of anxiety-related thoughts in anticipation of mental arithmetic and changes in diastolic blood pressure and heart rate during mental arithmetic.

Entities:  

Mesh:

Year:  1989        PMID: 2605437     DOI: 10.1192/bjp.155.1.86

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

Review 1.  [Panic disorder and its psychological treatment].

Authors:  J Margraf; M Ruhmland
Journal:  Naturwissenschaften       Date:  1996-09

2.  Anxiogenic properties of yohimbine. II. Influence of experimental set and setting.

Authors:  M Albus; T P Zahn; A Breier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 3.  Episodic memories in anxiety disorders: clinical implications.

Authors:  Armin Zlomuzica; Dorothea Dere; Alla Machulska; Dirk Adolph; Ekrem Dere; Jürgen Margraf
Journal:  Front Behav Neurosci       Date:  2014-04-24       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.